308 related articles for article (PubMed ID: 27079247)
1. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?
McCann M; Fitzpatrick F; Mellotte G; Clarke M
Am J Infect Control; 2016 Aug; 44(8):948-9. PubMed ID: 27079247
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
3. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Goudet V; Timsit JF; Lucet JC; Lepape A; Balayn D; Seguin S; Mimoz O
Trials; 2013 Apr; 14():114. PubMed ID: 23782845
[TBL] [Abstract][Full Text] [Related]
4. 2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial.
Kieran EA; O'Sullivan A; Miletin J; Twomey AR; Knowles SJ; O'Donnell CPF
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F101-F106. PubMed ID: 29074717
[TBL] [Abstract][Full Text] [Related]
5. 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheterisation: the ARCTIC randomised controlled feasibility trial.
Clarke P; Soe A; Nichols A; Harizaj H; Webber MA; Linsell L; Bell JL; Tremlett C; Muthukumar P; Pattnayak S; Partlett C; King A; Juszczak E; Heath PT
Arch Dis Child Fetal Neonatal Ed; 2024 Feb; 109(2):202-210. PubMed ID: 37907266
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
[TBL] [Abstract][Full Text] [Related]
7. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
9. Skin antisepsis: using 2% chlorhexidine gluconate in 70% isopropyl alcohol.
Inwood S
Br J Nurs; 2007 Dec 13-2008 Jan 9; 16(22):1390, 1392-4. PubMed ID: 18361387
[TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
12. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
[TBL] [Abstract][Full Text] [Related]
13. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.
Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP
Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848
[TBL] [Abstract][Full Text] [Related]
14. Needleless connector decontamination for prevention of central venous access device infection: A pilot randomized controlled trial.
Rickard CM; Flynn J; Larsen E; Mihala G; Playford EG; Shaw J; Keogh S; Ullman A; Zhang L; Gavin N; Kleidon T; Chopra V; McCarthy AL; Rocha PK; Marsh N
Am J Infect Control; 2021 Feb; 49(2):269-273. PubMed ID: 32735809
[TBL] [Abstract][Full Text] [Related]
15. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
[TBL] [Abstract][Full Text] [Related]
16. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of adding 2% (w/v) chlorhexidine gluconate to 70% (v/v) isopropyl alcohol for skin disinfection prior to peripheral venous cannulation.
Small H; Adams D; Casey AL; Crosby CT; Lambert PA; Elliott T
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):963-5. PubMed ID: 18771405
[TBL] [Abstract][Full Text] [Related]
18. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin.
Bashir MH; Olson LK; Walters SA
Am J Infect Control; 2012 May; 40(4):344-8. PubMed ID: 21737178
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Prospective Study of the Order of Preoperative Preparation Solutions for Patients Undergoing Foot and Ankle Orthopedic Surgery.
Hunter JG; Dawson LK; Soin SP; Baumhauer JF
Foot Ankle Int; 2016 May; 37(5):478-82. PubMed ID: 26678427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
